AXE

2.38%

21.5¢ archer materials limited

Ann: Biochip gFET design for multiplexing sent to commercial fab, page-8

First 8 Last

Share
Profile

Follow
Tizard

1,117 Posts.

143

31/07/23

11:06

Post #: 69074683
Share

Originally posted by Geeris: ↑

Looks like the Bio chip design and use cases are being mapped out with speed.

- Testing for multiple diseases - with one chip

- Extend the life time of the device with re- usable bio sensors. As also explained here, the biosensors can be re tuned from one detection job to another target.

- Software is progressing towards automated data analysis, in other words high quality data from these sensors. I'm particularly interested in this because it gives end users a product that can generate the data they need, while also detecting and fine tuning the detection. All of these data points can be fed into further end user designed, proprietary AI algorithms that suit the end user specifically. Very large data sets are no longer necessary or used in bio tech these days because of ethical and privacy concerns. Instead a sample, a starting set is all that's needed to generate a synthetic set of data for research purposes. Saves a great deal of time. The End Users play the bigger role here with the data the biochip detects. Only domain experts can sift through data and identify the bio markers/ data points that's of use to them in their specialised fields of research.

This lab on a chip is geared towards detection of relevant biomolecules to aid in useful and quicker data analysis to aid the research into not just diagnosing but more importantly early detection and prevention of disease.

- the multiplex biochip has also been sent to a separate foundry , an entire 4 in sample wafer of it will be available for AXE to embed in its platform by end of year. A few more hardware design refinements will be necessary to house the chip. After which end users I think will be given the basic API drivers for it which they can build on with other machine learning algorithms to suit their research.

Recently Mo said that point of care is not what this chip is designed for, it's designed for lab use and now it's becoming clear that it's designed for medical labs and path labs to develop very capable,powerful and quick data analysis tools. I for one am super impressed with this path. These are the behind the scenes use cases that are not always apparent to the market, but then suddenly become the backbone of modern health. All in my opinion of course, and I wish AXE and all of us a clear path to end use and rapid take up when the product comes to fruition.

Expand

Morning @Geeris, another great simplification of progress by Archer, out of curiosity how do you think that the biochips ( or any sensitive part of its progress) would be transported to various foundries/partners etc
Cheers

AXE Price at posting: 56.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 15 more messages in this thread...

First 8 Last

Add AXE (ASX) to my watchlist

(20min delay)
Last 21.5¢		Change 0.005(2.38%)		Mkt cap ! $54.79M

Open	High	Low	Value	Volume
21.5¢	23.0¢	21.0¢	$87.37K	399.3K

Buyers (Bids)

No.	Vol.	Price($)
1	2400	21.5¢

Sellers (Offers)

Price($)	Vol.	No.
23.0¢	331934	2

View Market Depth

No.	Vol.	Price($)
1	2400	0.215
5	114629	0.210
6	135726	0.205
11	68304	0.200
2	20130	0.195

Price($)	Vol.	No.
0.230	331934	2
0.240	37777	4
0.245	30000	2
0.250	8150	2
0.255	28300	2

Last trade - 15.55pm 04/10/2024 (20 minute delay)

AXE (ASX) Chart

Ann: Biochip gFET design for multiplexing sent to commercial fab, page-8

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Biochip gFET design for multiplexing sent to commercial fab, page-8

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News